For Patients with ASTHMA/COPD
Effective August 1, 2023, AZ&Me’s PAP made changes to the availability of Symbicort through its PAP and it is no longer available to NEW patients. Existing patients can still get refills through 12/31/2023, but effective 1/1/2024, Symbicort will be fully removed from AZ&Me’s PAP.
Medications with Changes in Availability
Looking for recent updates? Be sure to log in to TPC and click on “Program Changes” in TPC under the research menu. All updates are posted there. Recent changes include:
Get Your Final Refills and Check TPC for Alternative Brand Options
-
Flovent Diskus, Flovent HFA, Imitrex Nasal Spray renewals must be submitted soon:
- 10/1/2023: No longer available to new patients
- 11/1/2023: Last day to submit a renewal application for existing patients
-
11/15/2023: Last day to submit a renewed Rx for existing patients
- 12/1/2023: Last day request a refill for existing patients
- 12/31/2023: Meds removed from PAP.
-
Teva Cares will provide refills for ProAir HFA for existing patients refills until 10/31/2023. The eligibility period for ProAir Respiclick was also extended to existing patients through 12/31/2023. New patients are not being enrolled.
Albuterol is the generic option available in TPC through Rx Outreach at $35 per inhaler, through AMP for clinic members, & NC MedAssist for NC state residents at no cost. Good Rx may offer coupon savings at around $25 per inhaler but may vary depending on the area your patient lives
-
AZ&Me will provide refills for Byetta, Daliresp, Faslodex, Iressa, Kombiglyze, Onglyza, Pulmicort Flexhaler & Qtern for existing patients through 12/31/2023. Effective 1/1/2024 these medications will be fully removed as most of these products have low usage.
Reminders: Programs Closed to New Patients
-
Lilly Cares products with limited availability to eligible enrolled patients include: Baqsimi, Straterra, Symbyax, Zyprexa & Zyprexa Zydis.
-
New patient applications for Trulicity are NOT being accepted due to high global demand but existing patients can continue to receive refills.
Medications Removed from PAP: Check for Substitutes in TPC
-
AbbVie has removed the following products from its PAP: Acuvail, Androgel, Bystolic, Carafate, Combigan, Estrace, Infed, Lexapro, Liletta, Lo Loestrin fe, Lumigan, Namenda (Namenda XR remains available), Pred Forte, Pylera & Rapaflo.
-
GSK has removed Advair Diskus, Advair HFA, & Beconase AQ for all patients.
Alternative brand-name medications from different PAPs will be added to the Substitutes section of TPC. Check the Research menu for more info on recent program changes in TPC.
|